Doctors - Clinical Research Informer

Doctors Discover Needle Lodged in 80-Year-Old Woman’s Brain

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 12, 2023

An elderly woman in Russia’s Far East was revealed on Wednesday to have lived for 80 years with an inch-long needle in her brain, after doctors made the unexpected discovery during a CT scan. Doctors believe the woman was the victim of a failed infanticide carried out by her parents, and said they would not […]

Doctors

Doctors Doctor Clinical Trials Clinical Trials

Should doctors refuse to treat obese patients?

World of DTC Marketing

MARCH 28, 2021

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. Susan knew she needed to lose weight, especially when her doctor told her that her A1C indicated that she was prediabetic.

Doctors

Doctors Doctor Medicine Production

Even on social media “listen to the doctor”

World of DTC Marketing

JULY 31, 2021

The post Even on social media “listen to the doctor” appeared first on World of DTC Marketing.com. The world of online health-seeking has become more complicated but with some common sense you can find HCPs who know that they are talking about.

Doctors

Doctors Doctor Vaccination Vaccine

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Doctors are consumers too! How DTC media impacts HCPs

Bio Pharma Dive

OCTOBER 19, 2020

The findings have implications for how pharma teams should think about their DTC and HCP efforts — they are no longer two separate marketing channels.

Doctors

Doctors Doctor Marketing

Alzheimer’s doctors see promise, limits in Lilly’s latest drug data

Bio Pharma Dive

MAY 10, 2023

While some see the new donanemab results as adding to a “watershed moment” in Alzheimer’s research, others say they reinforce the limitations of so-called anti-amyloid therapies.

Doctors

Doctors Doctor Drugs Research

Duchenne patient dies after receiving Sarepta gene therapy

Bio Pharma Dive

MARCH 18, 2025

The case may give doctors pause before prescribing the treatment in the future, some analysts wrote. A young man treated with Elevidys died of acute liver failure.

Gene Therapy

Gene Therapy Gene Doctor Doctors

After surprise trial failure, ALS doctors brace for one less treatment option

Bio Pharma Dive

MARCH 12, 2024

Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.

Doctors

Doctors Doctor Trials Drugs

November 21, 2024: Are Pragmatic Trials Living Up to the Promise of Improving Representativeness?

Rethinking Clinical Trials

NOVEMBER 21, 2024

The post November 21, 2024: Are Pragmatic Trials Living Up to the Promise of Improving Representativeness?

Trials

Trials Clinical Trials Clinical Trials Doctors

Teleconsultation positions itself as viable alternative to offset low doctor-to-population ratio & specialists shortage

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 23, 2023

Teleconsultation is seen as a viable alternative with low doctor-to-population ratio and shortage of specialists doctors. In fact, teleconsultation is seen to bridge this gap by allowing patients in remote areas to receive earlier diagnosis and treatment with low cost and faster follow-up check-ups.

Doctors

Doctors Doctor Clinical Trials Clinical Trials

Doctor entrepreneurs seek healthcare management expertise to initiate best practices at clinics: Raj Sehgal

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 6, 2023

India’s smart doctor promoters are seeking help of professional healthcare management companies to introduce best healthcare management practices in their establishments, said Raj Sehgal associate director, TR Lifesciences. This is because these clinics encounter challenges even as there are growth prospects.

Doctors

Doctors Doctor Clinical Trials Clinical Trials

GoodRx launches new push to draw in doctors

Bio Pharma Dive

OCTOBER 13, 2022

Targeting providers directly is a pivot for GoodRx, but the company sees an opportunity to capture more pharmaceutical advertising revenue, said executive Preeti Parikh.

Doctors

Doctors Doctor

ChatGPT outperforms trainee doctors in assessing respiratory illness in children

Pharma Times

SEPTEMBER 9, 2024

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs

Doctors

Doctors Doctor Nurses Research

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Bio Pharma Dive

JANUARY 30, 2025

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

FDA Approval

FDA Approval Doctor Doctors Drugs

‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 17, 2023

There’s a small fatty gland that sits behind your sternum and is often said to be ‘useless’ in adulthood.A

Doctors

Doctors Doctor Research Clinical Trials

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

Bio Pharma Dive

DECEMBER 15, 2022

Relyvrio, a drug developed by Amylyx Pharmaceuticals, is in high demand in ALS clinics across the U.S. Though some patients are already getting it, insurance coverage and out-of-pocket costs remain a source of anxiety.

Doctors

Doctors Doctor Medicine Development

Bluebird's top doctor to depart as company grapples with safety review

Bio Pharma Dive

MARCH 17, 2021

David Davidson has served as Bluebird's chief medical officer since 2012. He'll leave in one month, per a separation agreement with the company.

Doctors

Doctors Doctor

ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’

Pharma Times

MARCH 1, 2024

TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients

Doctors

Doctors Doctor

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

JULY 31, 2020

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations.

Sales

Sales Vaccination Vaccine Doctors

Opinion: Doctors who knowingly spread Covid-19 lies should be held accountable

STAT News

SEPTEMBER 27, 2022

Gavin Newsom that strengthens discipline for doctors who knowingly spread Covid-19 misinformation. Some comes from doctors spreading lies about unproven — and actually harmful — “treatments” for Covid-19 and promoting anti-vaccine conspiracy theories. The California State Legislature has sent a bill to Gov.

Doctors

Doctors Doctor Vaccination Vaccine

Ten-year survival data show long-term benefit of immunotherapy in melanoma

Bio Pharma Dive

SEPTEMBER 15, 2024

Final follow-up results suggest Opdivo and Yervoy could be close to a cure for some people with advanced melanoma, shifting how doctors administer follow-up care.

Doctor

Doctor Doctors

As ALS research booms, one treatment center finds itself in the spotlight

Bio Pharma Dive

DECEMBER 20, 2023

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research

Research Doctor Doctors Scientist

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

Bio Pharma Dive

NOVEMBER 29, 2022

However, some doctors aren’t yet convinced the medicine’s risks are worth its potential benefits. At a medical conference, the companies detailed clinical trial results that could help support approval of their drug, lecanemab.

Doctors

Doctors Doctor Drugs Clinical Trials

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

STAT News

APRIL 14, 2023

The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.

Doctors

Doctors Doctor Research

Doctor Reveals What Happens When You Stop Taking Ozempic

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 23, 2024

Drugs like Ozempic are very effective at helping most people who take them lose weight. Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger. But does weight come back when you stop using […]

Doctors

Doctors Doctor Hormones Drugs

ERs staffed by private equity firms aim to cut costs by hiring fewer doctors

NPR Health - Shots

FEBRUARY 11, 2023

One apparent effect: Hiring fewer doctors and more health care practitioners who earn far less. Increasingly, private equity firms shape staffing decisions at hospital emergency rooms, research shows. Image credit: Phil Fisk/Image Source via Getty Images)

Doctors

Doctors Doctor Research

After controversial approval, doctors are still debating how to use Biogen's Alzheimer's drug

Bio Pharma Dive

AUGUST 3, 2021

Nearly two months since Aduhelm became available, many physicians have yet to use the first treatment approved in the U.S. to slow Alzheimer's disease.

Doctors

Doctors Doctor Drugs

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

DECEMBER 22, 2021

But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness. Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations.

Sales

Sales FDA Approval Doctor Doctors

UK doctors sceptical of AI's role in treatment

pharmaphorum

SEPTEMBER 11, 2024

One in two UK doctors would not use GenAI to treat patients, but there was more willingness to use it for diagnostic purposes, survey finds

Doctors

Doctors Doctor

Diabetes advocacy group discourages use of compounded GLP-1 drugs

Bio Pharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Pharmacy

Pharmacy Doctor Doctors Drugs

Moderna's vaccine can last for weeks in a refrigerator, expanding an edge on rivals

Bio Pharma Dive

NOVEMBER 16, 2020

Pharmacies and doctor's offices should be able to store Moderna's shot on site, a crucial advantage for the mass immunization challenge that lies ahead.

Pharmacy

Pharmacy Doctor Doctors Vaccination

Biogen CEO to step down as company pulls back from Alzheimer's drug

Bio Pharma Dive

MAY 3, 2022

Michel Vounatsos, Biogen's CEO since 2017, will be replaced as the company "substantially" eliminates the commercial workforce around Aduhelm, which has generated paltry sales in the face of resistance from insurers and doctors.

Doctors

Doctors Doctor Sales Drugs

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

Bio Pharma Dive

OCTOBER 5, 2020

The availability of three vastly different, cutting-edge medicines for the rare disease has put patients, families and doctors in an unfamiliar position.

Doctor

Doctor Doctors Medicine Drugs

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

Bio Pharma Dive

AUGUST 30, 2024

Detailed results from the Helios-B study support summary findings disclosed in June. But they may not make vutrisiran the standard of care as easily as Alnylam hopes.

Doctors

Doctors Doctor

Sage offers details on launch of new postpartum depression pill

Bio Pharma Dive

FEBRUARY 14, 2024

The company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the first oral therapy for PPD, is off to a good start.

Doctor

Doctor Doctors

'Dramatic' study results for AstraZeneca, Daiichi drug suggest new way to treat aggressive breast cancer

Bio Pharma Dive

JUNE 5, 2022

A quarter century after Roche's Herceptin became an option for HER2-positive breast cancer, positive study results for Enhertu could push doctors to consider a new classification of "HER2 low" disease.

Doctors

Doctors Doctor Drugs

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

Bio Pharma Dive

MARCH 15, 2024

The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.

FDA Approval

FDA Approval Doctor Doctors Drugs

Obesity drug from Zealand shows potential in early trial

Bio Pharma Dive

JUNE 20, 2024

Interim study data suggest the Danish drugmaker can remain in the race to develop new kinds of weight loss drugs as doctors seek alternatives to the now dominant GLP-1s.

Drugs

Drugs Doctor Doctors Trials

King’s Doctoral Training Centre to investigate MS symptom management

Pharma Times

MAY 24, 2024

The lifelong autoimmune disease affects more than 150,000 people living in the UK

Doctors

Doctors Doctor

FDA approves AstraZeneca, Daiichi drug in breast cancer first

Bio Pharma Dive

AUGUST 5, 2022

Enhertu is the first targeted treatment cleared for breast cancers that are ‘HER2 low,’ a new classification that could change how doctors treat the disease.

FDA Approval

FDA Approval Doctor Doctors Drugs

Expert Explains Why You Should Clean Your Tongue Twice a Day

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 25, 2024

(Science Photo Library/Getty Images) Has your doctor asked you to stick out your tongue and say “aaah”? The doctor will look for any changes in the tongue’s surface or how it moves. While the GP assesses your throat, they’re also checking out your tongue, which can reveal a lot about your health.

Doctor

Doctor Doctors Clinical Trials Clinical Trials

AI system helps doctors identify patients at risk for suicide

Medical Xpress

JANUARY 3, 2025

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts in routine medical settings.

Doctors

Doctors Doctor

Pfizer settles Biohaven kickback claims case for $59.7m

Pharmaceutical Technology

JANUARY 27, 2025

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

Doctor

Doctor Doctors

UniQure offers a closer look at the leading hemophilia B gene therapy

Bio Pharma Dive

DECEMBER 8, 2020

Doctors on Tuesday got a more detailed idea of how the therapy works and who might be eligible to take it, as results from a late-stage trial were presented at ASH.

Gene Therapy

Gene Therapy Gene Doctor Doctors

‘The luckiest of the unlucky’: A Duchenne gene therapy brings hope to families — and tests the FDA

Bio Pharma Dive

MAY 7, 2023

Patient advocates and doctors are anticipating an approval this month of a treatment they believe to be a breakthrough for a deadly disease. But it’s not clear how well the therapy really works, putting the FDA in a difficult position.

Gene Therapy

Gene Therapy Doctors Doctor Gene

Doctors Discover Needle Lodged in 80-Year-Old Woman’s Brain

Should doctors refuse to treat obese patients?

Webinars

Trending Sources

Even on social media “listen to the doctor”

Webinars

Doctors are consumers too! How DTC media impacts HCPs

Alzheimer’s doctors see promise, limits in Lilly’s latest drug data

Duchenne patient dies after receiving Sarepta gene therapy

After surprise trial failure, ALS doctors brace for one less treatment option

November 21, 2024: Are Pragmatic Trials Living Up to the Promise of Improving Representativeness?

Teleconsultation positions itself as viable alternative to offset low doctor-to-population ratio & specialists shortage

Doctor entrepreneurs seek healthcare management expertise to initiate best practices at clinics: Raj Sehgal

GoodRx launches new push to draw in doctors

ChatGPT outperforms trainee doctors in assessing respiratory illness in children

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

Bluebird's top doctor to depart as company grapples with safety review

ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’

Vaccine sales driven down by pandemic's effects on doctor visits

Opinion: Doctors who knowingly spread Covid-19 lies should be held accountable

Ten-year survival data show long-term benefit of immunotherapy in melanoma

As ALS research booms, one treatment center finds itself in the spotlight

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

Doctor Reveals What Happens When You Stop Taking Ozempic

ERs staffed by private equity firms aim to cut costs by hiring fewer doctors

After controversial approval, doctors are still debating how to use Biogen's Alzheimer's drug

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

UK doctors sceptical of AI's role in treatment

Diabetes advocacy group discourages use of compounded GLP-1 drugs

Moderna's vaccine can last for weeks in a refrigerator, expanding an edge on rivals

Biogen CEO to step down as company pulls back from Alzheimer's drug

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

Sage offers details on launch of new postpartum depression pill

'Dramatic' study results for AstraZeneca, Daiichi drug suggest new way to treat aggressive breast cancer

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

Obesity drug from Zealand shows potential in early trial

King’s Doctoral Training Centre to investigate MS symptom management

FDA approves AstraZeneca, Daiichi drug in breast cancer first

Expert Explains Why You Should Clean Your Tongue Twice a Day

AI system helps doctors identify patients at risk for suicide

Pfizer settles Biohaven kickback claims case for $59.7m

UniQure offers a closer look at the leading hemophilia B gene therapy

‘The luckiest of the unlucky’: A Duchenne gene therapy brings hope to families — and tests the FDA

Stay Connected